Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness
Cancers · 16.01.2024 · 16 (2) · 380
DOI: 10.3390/cancers16020380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.01.2024. Verfasst von Arkadiusz Kacała und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Interventional and Neuroradiology, Wroclaw Medical University, 50-367 Wrocław, Poland. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
This study evaluates the effectiveness of superselective transcatheter arterial chemoembolization (TACE) using a bleomycin–lipiodol emulsion in treating giant hepatic hemangiomas. A retrospective review included 31 patients with a mean age of 53 ± 10.42 years who underwent TACE from December 2014 to October 2022, with follow-up imaging examinations to assess outcomes. Technical success was defined as successful embolization of all feeding arteries, and clinical success was defined as a reduction in hemangioma volume by 50% or more on follow-up imaging. This study observed a 100% technical success rate. Post-embolization syndrome was common, and two cases of asymptomatic hepatic artery dissection were noted. Clinical success was achieved in 80.6% of patients, with significant volume reduction observed in the majority. Conclusively, superselective transcatheter arterial chemoembolization with bleomycin–lipiodol emulsions is presented as a viable and effective treatment option for giant hepatic hemangiomas. With no procedure-related mortality and significant volume reduction in most cases, this method offers a promising alternative to surgical intervention. This study’s findings suggest a need for further exploration and validation in larger-scale prospective studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General, Interventional and Neuroradiology, Wroclaw Medical University, 50-367 Wrocław, Poland.
- Faculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.
- Department of General, Interventional and Neuroradiology, Wroclaw University Hospital, 50-556 Wrocław, Poland.
- Department of Vascular, General and Transplantation Surgery, Wroclaw Medical University, 50-367 Wrocław, Poland.
ORCID-Profile: Arkadiusz Kacała, Mateusz Dorochowicz, Adrian Korbecki, Michał Puła, Dariusz Patrzałek, Maciej Guziński
Förderung
- Wroclaw Medical University
Zitieren
APA
Kacała, A., Dorochowicz, M., Korbecki, A., Sobański, M., Puła, M., Patrzałek, D., Janczak, D., & Guziński, M. (2024). Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness. Cancers, 16(2), 380. https://doi.org/10.3390/cancers16020380
Vancouver
Kacała A, Dorochowicz M, Korbecki A, Sobański M, Puła M, Patrzałek D, et al. Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness. Cancers. 2024;16(2):380. doi:10.3390/cancers16020380
BibTeX
@article{Kacaa2024,
author = {Kacała, Arkadiusz and Dorochowicz, Mateusz and Korbecki, Adrian and Sobański, Michał and Puła, Michał and Patrzałek, Dariusz and Janczak, Dariusz and Guziński, Maciej},
title = {Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness},
journal = {Cancers},
year = {2024},
volume = {16},
number = {2},
pages = {380},
doi = {10.3390/cancers16020380}
}
EUVIMED